ACTA HISTOCHEMICA, a prestigious journal published by Elsevier GmbH, is dedicated to advancing the field of histochemistry and its applications within cell biology and medicine. With an ISSN of 0065-1281 and an E-ISSN of 1618-0372, the journal provides a critical platform for the dissemination of high-quality research findings and reviews, integral for both emerging and established scholars. Since its inception in 1954 and continuing through to 2024, ACTA HISTOCHEMICA has maintained a strong commitment to publishing significant advancements in histology and cell biology, as evidenced by its categorization in Q3 for Cell Biology and Histology, as well as Q2 in miscellaneous medicine for the year 2023. The journal ranks favorably in Scopus, holding the 27th rank in Histology and a 200th rank in Cell Biology, highlighting its importance to the academic community. With its headquarters in Munich, Germany, ACTA HISTOCHEMICA continues to attract contributions from global researchers, fostering an international dialogue essential for the growth of knowledge in histochemistry and related disciplines.

JOURNAL OF HISTOTECHNOLOGY, published by Taylor & Francis Ltd, is a leading academic journal dedicated to advancing the field of histotechnology, which plays a crucial role in both clinical and research settings. With an established history since 1977, this journal serves as a critical platform for researchers, professionals, and students engaged in the intricate study of tissue processing, staining techniques, and microscopic analysis. It is currently indexed in reputable databases, reflecting its commitment to scientific rigor, with a notable presence in categories such as Anatomy, Histology, and Medical Laboratory Technology. Despite its open access status being limited, the Journal of Histotechnology maintains a respectable impact factor and ranks within the third quartile for Anatomy and Medical Laboratory Technology, and fourth quartile for Histology in 2023, emphasizing its relevance in the scholarly community. As the field continues to evolve, this journal aims to foster innovation and dissemination of knowledge within histotechnology, making it an essential resource for those looking to further their expertise and contribute to the advancements in this vital area of health sciences.

CELL AND TISSUE RESEARCH, published by Springer, is a premier journal dedicated to advancing the field of cell biology, histology, pathology, and forensic medicine. With a proud history dating back to its foundation in 1924 and continuing its legacy, this journal has established itself as a vital source for innovative research, facilitating the dissemination of significant findings that contribute to the understanding of cellular and tissue dynamics. Hailing from Germany, the journal exhibits an impressive standing in the academic community with a 2023 impact factor reflected in its category quartiles: Q2 in Cell Biology, Q1 in Histology, and Q1 in Pathology and Forensic Medicine. It ranks notably within multiple Scopus categories, including 32/208 in Pathology and Forensic Medicine and 13/62 in Histology, showcasing its high percentile rankings of 84th and 79th, respectively. Researchers, professionals, and students benefit from its extensive coverage and rigorous peer-review process that ensures the integrity and relevance of its published works, thus making it an essential resource in the scientific community. While it operates under a subscription model, its commitment to quality and impact makes it an indispensable journal for anyone engaged in cellular and tissue research.

Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology, an esteemed journal published by WILEY, serves as a pivotal platform for scholars in the fields of anatomy, biotechnology, ecology, evolutionary biology, and histology. With an ISSN of 1932-8486 and an E-ISSN of 1932-8494, this journal has demonstrated its academic rigor by maintaining a Q2 ranking across multiple relevant categories, including Anatomy and Biotechnology, and consistently achieving a high Scopus ranking in its respective fields. Its scope, covering integrative approaches to anatomical research and evolutionary studies, fosters interdisciplinary collaboration and innovation. Researchers and practitioners can access the journal through various open-access options, ensuring that groundbreaking findings are disseminated widely. As a vital resource for advancing knowledge and exploring emerging trends, this journal greatly contributes to the understanding of biological systems and evolutionary processes, making it an essential read for those dedicated to pushing the boundaries of their respective disciplines.

CELLULAR AND MOLECULAR LIFE SCIENCES, published by SPRINGER BASEL AG, stands as a premier journal dedicated to advancing the field of cellular and molecular biology. With an impressive 2023 impact factor reflected in its Q1 rankings across key categories—including Cell Biology, Molecular Biology, and Pharmacology—it serves as a critical platform for researchers aiming to disseminate high-quality findings in these dynamic fields. Operated under an open access framework, the journal allows broader accessibility to groundbreaking research, fostering collaboration amongst scientists globally. Based in Switzerland, CELLULAR AND MOLECULAR LIFE SCIENCES has been at the forefront of scientific publishing since 1952, adapting to contemporary scientific challenges and trends, ultimately shaping the future of life sciences.

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

ANATOMIA HISTOLOGIA EMBRYOLOGIA, published by Wiley, is a well-regarded journal that serves as a vital resource in the field of anatomy and histology, with a particular emphasis on embryological studies. Established in 1972, this journal fosters cutting-edge research and discussions that deepen our understanding of the intricate relationships between structure and function across various species, while also addressing the parallels within veterinary and medical contexts. Though currently not open access, the journal maintains a significant impact within its scope, evidenced by its strong performance in Scopus rankings, particularly in the veterinary sciences, where it stands at rank #81 out of 194. With its dedicated focus on progressive scientific inquiry and publication regularly until 2024, the journal is committed to advancing knowledge and providing a platform for scholars, researchers, and practitioners alike. ANATOMIA HISTOLOGIA EMBRYOLOGIA is pivotal for those aiming to engage with the latest findings and methodologies in the fields of medicine and veterinary science, ensuring it remains an essential addition to any academic library.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

MOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.

CELL is a premier academic journal in the field of Biochemistry, Genetics, and Molecular Biology, published by CELL PRESS. Founded in 1974, this esteemed journal has steadfastly contributed to advancing our understanding of cellular processes and organisms, making it integral for researchers and practitioners alike. With an impressive impact factor that places it in the Q1 category of its field, CELL ranks #1 out of 221 in general biochemistry and genetics, achieving a remarkable 99th percentile in Scopus rankings. Though it is not currently an open-access publication, the journal regularly disseminates high-quality research that impacts the scientific community significantly. Researchers, students, and professionals seeking to stay at the forefront of innovative discoveries and methodologies in molecular biology will find CELL an invaluable resource through its comprehensive articles and reviews.